InvestorsObserver
Sign Up Login

HGEN Humanigen Inc

$2.05 $0.00 (0.24%)
Add to Watchlist Compare
Overall

HGEN Stock Analysis Overview

What this means: InvestorsObserver gives Humanigen Inc (HGEN) an overall rank of 43, which is below average. Humanigen Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 43 means that 57% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

HGEN Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

HGEN Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

HGEN Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

HGEN Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

HGEN Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

HGEN Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

HGEN Stock Analysis Overview

What this means: InvestorsObserver gives Humanigen Inc (HGEN) an overall rank of 43, which is below average. Humanigen Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 43 means that 57% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full HGEN report

HGEN Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

HGEN Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

HGEN Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

HGEN Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

HGEN Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

HGEN Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Humanigen Inc (HGEN) Analyst Forecast

HGEN Price, Volume, Earnings, and Dividend Date

  • Last Price $2.05
  • Previous Close $2.05
  • Change $0.00
  • Open $2.02
  • Volume 1,010,028
  • Avg. Volume (100-day) 1,441,323
  • Market Cap 144,799,095
  • Days Range 1.92 - 2.14
  • 52-week Range 1.67 - 23.53
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 08/03/22
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 0.684
  • PEG Ratio —

Humanigen Inc (HGEN) Company Description

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.

Humanigen Inc (HGEN) Stock Chart

View Interactive HGEN chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
Point Biopharma Global Inc (PNT) (PNT) $7.91
Catalyst Bio (CBIO) (CBIO) $1.11
Concert Pharmaceutic (CNCE) (CNCE) $5.02
SC Pharmaceuticals Inc (SCPH) (SCPH) $4.90
Veru Inc (VERU) (VERU) $12.64
Mirum Pharmaceuticals Inc (MIRM) (MIRM) $24.58
Adma Biologics (ADMA) (ADMA) $1.94
Fennec Pharmaceuticals Inc (FENC) (FENC) $5.78
Tricida Inc (TCDA) (TCDA) $8.08
Vaxcyte Inc (PCVX) (PCVX) $25.86